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Expression of the human papillomavirus type 11 E1 and E2 genes is necessary and sufficient to support viral DNA
replication. The full-length E2 protein is a transcriptional modulator that also interacts with the E1 helicase to form an E1/E2
complex at the viral origin of replication. Previous studies indicated that efficient binding of this complex to the replication
origin is site-specific and that the E2 homodimer was required for efficient E1 binding. Human papillomavirus type 11 E2 and
E1 proteins have been purified and their cooperative binding to the HPV type 11 viral replication origin has been
characterized. Low-affinity E1 binding to the HPV type 11 replication origin was demonstrated and found to be largely
nonspecific. DNA binding by E1 does not require complex formation with E2 and appears to be independent of ATP binding
or hydrolysis. E1 binding quantitatively increased with the addition of increasing amounts of E2 and mutations in the E2
binding site demonstrated that the E2BS site is required for E1 and E2 to specifically bind as a high-affinity complex at the
replication origin. Analysis of the A/T-rich E1 binding site via mutation showed that it was nonessential for high-affinity E1/E2
complex formation. Thus, although the replication functions between the animal and the human papillomaviruses are well
conserved, there are subtle differences in the DNA binding requirements for E1, which may portend mechanistic differences
among the DNA replication systems of various papillomavirus types. © 2000 Academic Press
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a
oINTRODUCTION
Human papillomaviruses are members of a family of
small DNA tumor viruses that induce benign epithelial
lesions and neoplasias. HPV infection can result in mul-
tiple clinical manifestations, including benign cutaneous
warts, sexually transmitted genital warts, laryngeal pap-
illomas, cervical dyplasias, and genital cancers. More
than two dozen of the nearly 100 different HPV types are
associated with epithelial lesions of the oral and ano-
genital mucosa. These lesions can be divided into low-
and high-risk groups based upon their association with
malignant progression (zur Hausen, 1991).
In benign lesions, basal epithelial cells maintain the
viral genome at a low copy number as a stable replicat-
ing episome. In productive lesions, viral DNA amplifica-
tion occurs concomitantly with the induction of late gene
expression in differentiating keratinocytes. Thus, the rep-
licative life cycle of the virus involves several stages
including establishment, stabilization or maintenance,
and genome amplification in differentiated epithelial
cells. A detailed understanding of the cellular and viral
1 To whom correspondence and reprint requests should be ad-
ressed at Department of Virology, Glaxowellcome Co., Five Moore1
rive, Building RC2, Room 3521, Research Triangle Park, NC 27709.
ax: (919) 315-5243. E-mail: wcp41432@glaxowellcome.com.
345factors that regulate the various replicative stages will
contribute much to our understanding of the HPV life
cycle and pathology.
Numerous studies have demonstrated that, in addition
to host cell DNA replication factors, only two viral pro-
teins, E1 and E2, are necessary to support origin-depen-
dent replication (Ustav and Stenlund, 1991). The minimal
origin of replication consists of a region spanning ap-
proximately 60–80 bp that contains an A/T-rich element,
a palindromic E1 binding site, and two 12-bp palindromic
elements that constitute binding sites for E2 (Lu et al.,
1993; Russell and Botchan, 1995; Ustav et al., 1991). In
contrast to BPV replication, however, the role of the E1
binding site in HPV replication is less clear and perhaps
more variable. Several studies have suggested that al-
though one or more E2 binding sites are required for
HPV replication, the putative E1 binding site can be
deleted, suggesting that regulation of initiation may be
somewhat different (Chiang et al., 1992a).
The E1 protein is a 72-kDa nuclear phosphoprotein
that like SV40 T antigen binds to the origin and has
ATPase, helicase, and origin unwinding activities (Bream
et al., 1993; Holt et al., 1994; Seo et al., 1993b; Sun et al.,
990; Thorner et al., 1993; Yang et al., 1993). Unlike T
ntigen, E1 has only a modest affinity and specificity for
rigin DNA (Sedman and Stenlund, 1995; Sedman et al.,
997), instead being recruited to the origin through co-
0042-6822/00 $35.00
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346 DIXON ET AL.operative binding with E2. E2, a 48-kDa transcriptional
transactivator, demonstrates high-affinity sequence-spe-
cific binding to the origin (Alexander and Phelps, 1996;
McBride et al., 1991; Monini et al., 1991; Sanders and
Maitland, 1994). E2 can form a complex with E1 in the
absence of DNA (Blitz and Laimins, 1991; Lusky and
Fontane, 1991; Mohr et al., 1990), resulting in a reciprocal
enhancement of DNA binding: E2 enhances E1 binding
and E1 enhances E2 binding (Chao et al., 1999). E2
consists of three functional domains, a transactivation
domain within the amino-terminal 200 amino acids, a
central flexible hinge, and a DNA binding and dimeriza-
tion domain located in the carboxyl-terminal 90 residues.
E2 dimers bind avidly and specifically to the palindromic
sequence ACCN6GGT. All known papillomaviruses con-
tain multiple copies of the E2 binding site including some
that are critical to efficient regulation of the viral origin.
Sequence-specific origin binding has been demon-
strated for BPV E1 by numerous techniques including
McKay assay, filter binding, DNA footprinting, and elec-
trophoretic mobility shift assay (EMSA) (Sedman et al.,
1997; Seo et al., 1993b; Thorner et al., 1993; Ustav et al.,
991; Wilson and Ludes-Meyers, 1991). In contrast, HPV
1 origin binding in the absence of E2 has been more
ifficult to convincingly demonstrate due to a lower in-
rinsic binding affinity and substantial difficulties in pro-
ein purification. Most previous work has been with par-
ially purified HPV E1 or fusion proteins (Frattini and
aimins, 1994a,b; Liu et al., 1995; Sun et al., 1996). To
urther explore the interplay of viral and cellular proteins
ith the HPV origin of replication, a detailed analysis of
ighly purified, unfused HPV11 E1 was initiated. In this
ork, we demonstrate that HPV11 E1 binds to the origin
f replication without apparent sequence specificity, sug-
esting that an E1 binding site in the origin plays little or
o role in viral DNA replication.
RESULTS
BPV-1 E1 has been reported to bind specifically to the
iral origin of replication to initiate viral DNA replication
Sedman and Stenlund, 1996; Wilson and Ludes-Meyers,
991). In part through analogy to the BPV origin, the
PV-11 origin of replication has been localized to a
02-bp A/T-rich region containing a putative E1 binding
ite in an AT-rich region and three high-affinity E2 binding
ites (Russell and Botchan, 1995; Sun et al., 1996). Since
he HPV E1 binding site is thought to be conserved, yet
aradoxically appears to be dispensable for HPV repli-
ation, we undertook a study of the individual and coop-
rative binding activities of HPV11 E1 and E2 to the
rigin. In previous, unpublished studies from this labo-
atory, a consensus DNA binding site for HPV11 E1 was
ought through multiple rounds of selection of random
ligonucleotides (Tuerk and Gold, 1990). After threeounds of selection by immune precipitation, sequencing Ef 40 individual DNA clones failed to reveal a single,
lear consensus sequence analogous to the binding site
f BPV E1. Instead, the data suggested only that HPV11
1 bound DNA sequences with high AT content as ;90%
f the selected clones contained .30% T on one strand
G. Bream and W. Phelps, unpublished results). To facil-
tate further studies involving HPV-11 viral DNA replica-
ion, full-length, unfused HPV-11 E1 and E2 proteins were
xpressed in Trichoplusia ni insect cells and purified to
95% homogeneity by antibody affinity chromatography
Rocque et al., 2000). We utilized these highly purified E1
nd E2 proteins in EMSA to assess their relative affinities
or sequence-specific origin binding.
PV-11 E1 origin binding
Among the human and animal papillomaviruses, the
rganization of the origin of replication is well conserved
s depicted in Fig. 1A. A binding site for BPV E1 was
efined several years ago by various techniques and is
entered over the HpaI restriction enzyme site (gray box
n Fig. 1A). DNase footprinting identified a similar region
n HPV 31 (open box in Fig. 1A) that bound GST-E1
Frattini and Laimins, 1994b). To study HPV11 E1 DNA
inding, we used oligonucleotide probes depicted in Fig.
B and, to simplify the analysis, the double-stranded
NA probes contained single binding sites for both E1
nd E2. These included a wild-type probe spanning nu-
leotides 7904 to 50 of the HPV-11 origin, E2 and E1
inding site mutants, as well as scrambled and nonspe-
ific oligonucleotides of comparable size. Highly purified
PV11 E1 protein was incubated with a biotinylated DNA
ragment and bound complexes were fractionated by
garose gel electrophoresis and visualized using chemi-
uminescence. Where appropriate, the protein composi-
ion of the complexes was verified with monoclonal an-
ibodies directed against E1 and E2, which supershift
ound complexes.
Presumably due to the low intrinsic stability of the
1/DNA complex, standard analysis of E1 binding by
MSA fails to demonstrate complexes in the absence of
2. Therefore, conditions were developed following
hose described for BPV E1, which utilize gluteraldehyde
ross-linking to visualize the low-affinity complexes. The
ddition of E1 alone to the origin DNA resulted in a low
ut demonstrable association as evidenced by the ap-
earance of one or more slowly migrating complexes
hat quantitatively increased with higher concentrations
f E1 from 100 to 500 ng (Fig. 2, lanes 2–6). Furthermore,
hen the E1/DNA complex was incubated with a mono-
lonal antibody specific for HPV11 E1, the complex was
upershifted, confirming the presence of E1 (Fig. 2, lane
). This monoclonal antibody, 82.15, was mapped to an
pitope within amino acids 170–176, which is thought to
ie to the N-terminal side of the DNA binding domain of
1. A second antibody, 43.13C, which mapped to an
p ies. W
( lanking
347BINDING OF HPV TYPE 11 E1 HELICASE TO ORIGIN OF REPLICATIONepitope within amino acids 302–325, interfered with DNA
binding (data not shown), consistent with location of this
epitope within the putative DNA binding domain.
HPV-11 E2 interacts directly with HPV-11 E1 at the
origin of replication
To date, most studies of the E1/E2/origin interaction
have focused on BPV. In these studies, it has been
clearly shown that full-length E2 interacts directly with E1
and enhances E1 binding to the origin of replication (Blitz
and Laimins, 1991; Mohr et al., 1990; Seo et al., 1993a).
Since it has been difficult to directly observe binding of
HPV E1 to DNA in the absence of E2, cooperativity has
been principally observed as an all-or-none phenome-
non. With the purification of HPV11 E1 and the establish-
ment of conditions to readily observe its individual bind-
ing characteristics, we sought to further explore the
cooperativity of E2.
We generated HPV11 E2 protein by expressing full-
length E2 in Escherichia coli and purifying the E2 protein
to .95% homogeneity by DNA affinity chromatography
(Chao et al., 1999). As expected, incubation of full-length
E2 resulted in a specific association with the origin (Fig.
3, lane 2). Incubation of the protein/DNA complexes with
a monoclonal antibody to HPV11 E2 (epitope aa 341–518)
supershifts the E2/DNA complex, verifying the presence
FIG. 1. (A) Papillomavirus origins. The nucleotide sequences encom
showing general conservation of the E2 binding sites E2BS , AT-rich
mapped to a region centered on the HpaI site ( GTTAAC ) and a comp
robes. Shown are the DNA sequences of probes used in binding stud
nt 35–46) and the putative E1 binding site within the AT-rich region. Fof E2 (Fig. 3, lane 12).Since E1 and E2 individually bind to the origin of
replication, and it is known that E1 and E2 can associate
and cooperatively bind to the origin, it was important to
examine in more detail how E2 influences the DNA
binding capabilities of E1. E2 was titrated to confirm,
under the binding conditions employed, that E2 was
subsaturating for binding to the origin through the single
E2BS (data not shown). The addition of HPV-11 E2 pro-
tein at a constant, subsaturating amount, 20 ng (24 nM),
in the presence of increasing amounts of E1 stimulated
binding to the origin as evidenced by the appearance of
a slowly migrating complex (Fig. 3, lanes 4–7). The pu-
tative E1/E2/DNA complex migrates somewhat more
slowly than the complex seen with E1 alone. Since mo-
lecular mass cannot be accurately inferred from migra-
tion in a nondenaturing gel, the presence of E2 in the
complex was confirmed by the addition of monoclonal
antibody. It should also be noted that as the concentra-
tion of E1 was increased, the E2-specific, faster migrat-
ing species concordantly disappeared presumably be-
cause E2 along with E1 was entering into the larger
complex. In a reciprocal experiment, in which the con-
centration of E1 is held constant at 100 ng (68 nM) and
E2 is increased from 1 to 100 ng, again it can be seen
that the addition of E2 stimulates formation of the large
origin complex (Fig. 3, lanes 8–11). In contrast to the
g the replication origins of HPV11, HPV16, HPV18, HPV31, and BPV1
ces, and E1 binding sites. The E1 binding sites for BPV1 have been
site mapped in the HPV31 origin TTTATA. . .AAA . (B) Oligonucleotide
t origin included sequences from nt 7904 to 50 and contained 1 E2BS
sequences consisted of 59-TATATAAACCAG-39 12-bp nucleotides.passin
sequen
arabletitration of E1, titration of E2 in the presence of constant
b
e
D
m
348 DIXON ET AL.E1 did not result in a linear response, perhaps due to the
competing binding reactions, E2 to E1 and E2 to the
E2BS. A similar titration of purified E2C encoding the
C-terminal 88 amino acids (Alexander and Phelps, 1996)
failed to stimulate formation of the slow migrating origin
complex (data not shown), verifying that cooperative
binding requires a functional amino-terminal domain for
recruitment of E1 to the origin. To verify that both E1 and
E2 remain together in the slow migrating origin complex,
monoclonal antibodies were used to supershift the
slower migrating form. Compare lane 6 to lanes 12 and
13 (Fig. 3).
The role of ATP binding and hydrolysis
Throughout these studies, we examined the role of
ATP binding and hydrolysis in the assembly of the E1/
E2/origin complex. HPV-11 E1 contains conserved con-
sensus sites for nucleotide binding and has been shown
in several studies to encode ATPase activity (Bream et
al., 1993). Initially, we examined the effects of ATP on E1
inding to the origin. In contrast to previous studies (Liu
t al., 1995), we saw no quantitative or qualitative effects
FIG. 2. DNA binding activities of E1. Assays were performed with a
92-bp origin probe containing a single binding site for both E1 and E2.
Lane 1 represents the migration of the DNA probe. Lanes 2–6 show
migration of the probe after the addition of increasing amounts of
purified E1 protein (100–500 ng) as described under Materials and
Methods. Lane 7 shows migration of the probe in the presence of
purified E1 and an anti-E1 mouse monoclonal antibody (82.15). DNA–
protein complexes were cross-linked with 0.02% glutaraldehyde, sep-
arated by electrophoresis in TBE agarose gels, electrotransferred, and
visualized by chemiluminescence.following addition of ATP or a nonhydrolyzable analog,59-adenylylimidodiphosphate (Sigma A-2647) (data not
shown). In addition, we examined the effects of ATP on
the stimulation of complexation in the presence of both
E1 and E2. In contrast to studies with BPV (Sanders and
Stenlund, 1998), in our hands, the addition of ATP neither
stimulated complex formation nor resulted in the dis-
placement of E2 (data not shown).
During initial characterization of purified HPV11 E1,
several putative ATPase knockout mutants were con-
structed, expressed, and purified from baculovirus. Mu-
tant E1 proteins were partially purified by column chro-
matography then assayed for DNA binding activities.
One mutant, a proline to serine change (P479S), exhib-
ited both wild-type DNA binding (Fig. 4A) and ATPase
activities. This result was surprising since reports using
HPV-6 E1 indicated that an equivalent proline to serine
change abolished ATPase activity (Hughes and Roma-
nos, 1993). A lysine to glutamic acid change at 484
completely disrupted DNA binding and its ability to in-
teract with E2 (Fig. 4B) and was defective for ATPase and
in vitro replication (Table 1). Since this particular mutant
protein also demonstrated a decreased affinity for the
82.15 antibody, we suspect that the tertiary structure was
substantially altered. Only a limited amount of origin
binding is seen with K484E, possibly due to conforma-
tionally disrupted or monomeric E1. Aspartic acid to as-
paragine changes at positions D523N and D542N se-
verely reduced the levels of ATPase and replication, yet
were still able to bind DNA at equivalent amounts com-
pared to the wild-type protein (Fig. 4C). Taken together,
these results indicate that neither ATP binding nor hy-
drolysis is required in the formation of the E1/E2/origin
complex.
The E2 binding site is critical for E1/E2/DNA high-
affinity complex formation
To determine the relative importance of the E2BS and
the putative E1BS in the origin, site-specific mutations
that individually inactivated each of the two binding sites
were constructed (Fig. 1B). Numerous, detailed studies
of the E2BS have been published to guide the selection
of binding mutations. In contrast, since detailed studies
of E1 DNA binding have not been published, we con-
structed a putative E1BS knockout based upon HPV11
origin mutants with significantly reduced in vitro origin
NA replication activity (Russell and Botchan, 1995; Sed-
an and Stenlund, 1995; Sun et al., 1996). Figure 5 shows
the results of experiments in which biotinylated wild-type
probe was mixed with E1 or E2 in the presence of
different unlabeled DNA species (253 molar excess).
Competition for binding was used as a measure of the
relative binding activities of the unlabeled oligonucleo-
tides. As shown previously, HPV-11-E1 alone or E2 alone
can bind to the origin of replication and E2 can stimulate
binding of E1 to DNA (Fig. 5, lanes 1–4). Competition with
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349BINDING OF HPV TYPE 11 E1 HELICASE TO ORIGIN OF REPLICATIONunlabeled wild-type probe led to a substantial reduction
in signal (Fig. 5, lanes 5–7). Ablation of the E2 binding
site in the cold competitor oligonucleotide completely
inhibited its ability to interfere with formation of the origin
complex (Fig. 5, lanes 14–16). Somewhat surprisingly, a
mutation in the putative E1BS had no effect on the ability
of the unlabeled oligo to compete with the labeled wild
type (compare lanes 11–13 to lanes 5–7). Consistent with
the observation that mutation of the E1BS has no appar-
ent effect on formation of the origin complex, the double-
mutant probe (MUT E1/E2) acted like the single mutant
(Mut E2) and was unable to compete with the wild-type
probe (compare lanes 17–19 to lanes 14–16). Finally, a
control, scrambled oligonucleotide lacking both E1 and
E2 binding sites is also unable to effectively compete
with wild type (lanes 8–10). Thus, the presence or ab-
sence of the putative E1BS had no effect on the ability of
the cold oligo to compete (WT, Mut E1), while mutation of
the E2BS (Mut E2, Mut E1/E2, SCRM) rendered the cold
oligonucleotide noncompetitive.
The above results suggest that although the E2BS is
critical to recruitment of E1 to the origin, the putative
E1BS may be dispensable as E1 has no clear sequence
specificity in the absence of E2. To confirm this obser-
vation, E1 binding in the absence of E2 protein to the
wild-type origin probe was competed with 5–1003 ex-
FIG. 3. Cooperative binding of E1 and E2 to the HPV11 origin. Lane
HPV-11 E1; lanes 4 to 7, probe plus increasing amounts of HPV-11 E1 (
8 to 11, probe plus increasing amounts of HPV-11 E2 (1–100 ng) in the p
anti-HPV-11 E2 antibodies 92-12A; lane 13, probe plus E1, E2, which iscess of unlabeled oligo. As can be seen in Fig. 6, com- fpetition of E1 binding was equivalent using either a
wild-type or a random oligonucleotide (RANBS) lacking
both known E1 or E2 binding sites and AT-rich se-
quences.
In vitro DNA replication
The above data predict that it is only the E2BS that
confers specificity to the assembly of an origin-depen-
dent replication complex in HPV11. To confirm this ob-
servation in a more functionally relevant context, we
utilized purified E1 and E2 proteins in cell free in vitro
DNA replication (Fig. 7). Previous studies (Liu et al., 1995)
ave shown that addition of HPV11 E1 and E2 to an in
itro reaction will stimulate origin-dependent replication.
nder standard conditions following a 2-h incubation, a
imple titration of E1 in the presence or absence of 20 ng
f E2 demonstrates a clear stimulatory effect of E2 in the
resence of ori sequences. With E1 alone, however,
here is no quantitative difference due to the presence of
rigin sequences. Thus, in the absence of E2, E1 seems
o bind nonspecifically to pUC18 sequences, with or
ithout an HPV11 origin, and initiate comparable levels
f DNA replication. In contrast, in the presence of E2
rotein, stimulation of replication is entirely dependent
n the presence of an E2BS-containing origin, suggest-
ng that with HPV11, origin specificity is exclusively con-
biotinylated probe; lane 2, probe plus HPV-11 E2; lane 3, probe plus
ng) in the presence of a constant amount of HPV-11 E2 (20 ng); lanes
e of a constant amount of HPV-11 E1 (100 ng); lane 12, supershift using
shifted using anti-HPV-11 E1 antibodies 82.15C.1, free
10–200
resencerred through E2 binding.
d
p
a
s
l
v
h
c
s
a
(
s
t
s
utant.
350 DIXON ET AL.Multimeric form of E1
Several studies of BPV E1 have indicated that E1 can
assemble to a hexamer in solution in the presence of
DNA (Fouts et al., 1999; Sedman and Stenlund, 1998). To
ate, no similar studies of an HPV E1 protein have been
ublished, though based upon homology to SV40 Tag
nd BPV E1, one would expect that HPV E1 would as-
emble to a hexameric helicase as well. Studies of full-
FIG. 4. Origin binding activity of HPV-11 E1 ATPase mutants. Consta
mutant E1 (50–200 ng) and examined for their ability to form complexes
incubated with anti-E1 monoclonal antibody 82.15 to detect specific
K484E-E1 mutant; (C) HPV-11-D523N-E1 mutant; (D) HPV-11-D542N-E1 m
E1 proteins.ength, unfused HPV11 E1 using both equilibrium and celocity sedimentation revealed that E1 is principally a
examer following purification from baculovirus. At low
oncentration, a small amount of monomer was ob-
erved, suggesting that in the absence of exogenously
dded DNA, a monomer–hexamer equilibrium may exist
Rocque et al., 2000). Therefore, the origin binding
tudies described above are likely to primarily represent
he activities of a hexameric form of HPV E1 as only a
mall fraction of monomer is thought to exist within the
unts of E2 (40 ng) were added to increasing amounts of wild-type or
e wild-type HPV11 origin. Reactions at the highest concentration were
oteins within the complex. (A) HPV-11-P479S-E1 mutant; (B) HPV-11-
Table 1 is a summary of the functional activities of wild-type and mutantnt amo
with th
HPV proncentration ranges employed. In addition, we have not
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351BINDING OF HPV TYPE 11 E1 HELICASE TO ORIGIN OF REPLICATIONthus far found conditions that will promote disassembly
or stabilize a monomeric form of E1.
DISCUSSION
The origin of replication is generally well conserved
among the human and animal papillomaviruses, and
studies have shown that both E1 and E2 proteins are
absolutely required for replication of the viral episome in
cell culture (Ustav and Stenlund, 1991). The conserved
core components that have been identified in the origin
include one or more E2 binding sites, an E1 binding site,
and an AT-rich element (McShan and Wilson, 1997; Ustav
et al., 1993). In part as a consequence and measure of
the overall conservation of the replication functions, het-
erologous mixtures of viral replication components from
both animal and human PVs can be utilized for replica-
TABLE 1
E1 Wild-type and Mutant Functional Activities
E1
construct
DNA
binding
ATPase
(mmol/min/mg protein)
In vitro replication
(%wt)
Wild type 11 0.08 100
P479S 11 0.08 50
K484Ea 2 Undetectable ,10
D523N 11 0.006 ,10
D542N 11 0.007 ,10
Note. 11, strong activity; 2, no activity.
a K484E bound the immunoaffinity column poorly; thus only Heparin
urified E1/K484E was tested for the above activities. The protein that
as recovered showed no activity.
FIG. 5. The E2 binding site is critical for E1/E2 cooperative binding.
Competition with unlabeled competitor DNA (253 molar excess) containing w
1), and a scrambled oligonucleotide (SCRM) was assessed by mixing labeledtion (Chiang et al., 1992b; Del Vecchio et al., 1992).
erhaps as expected, a more careful examination has
evealed subtle quantitative and qualitative differences
mong the replication components. For example, the E2
rotein from HPV11 cooperates very poorly with BPV E1
ue to unfavorable spacing in the BPV origin between
he E1 and the E2 binding sites (Berg and Stenlund, 1997)
ven though this heterologous combination will recog-
ize and replicate an HPV11 origin.
The prevailing model for initiation of papillomavirus
eplication has been largely derived from studies of BPV
Yang et al., 1991; Bonne-Andrea et al., 1997; Chen and
Stenlund, 1998; Ferguson and Botchan, 1996; Sarafi and
McBride, 1995; Sedman and Stenlund, 1996; Sedman et
al., 1997) and casts E1 as an origin binding helicase that
is recruited to its binding site (E1BS) in part, through
protein/protein interaction with the E2 viral transcription
factor. Recruitment of E1 is thought to be important to
BPV replication, because although E1 has been shown in
numerous studies to bind specifically to the E1BS in the
origin (Gillette et al., 1994; Holt et al., 1994; Wilson and
Ludes-Meyers, 1991), the affinity and sequence specific-
ity are considered low in the absence of E2 (Sanders and
Stenlund, 1998). BPV E1 is thought to assemble to an
active, hexameric helicase and recruit necessary cellular
replication factors including DNA pol a (Bonne-Andrea et
al., 1995; Park et al., 1994) in the formation of an active
replication complex.
The minimal origin in HPV-11 has been shown through
transient replication studies to be comparable to the
bovine papillomavirus type 1 origin of replication (Lu et
al., 1993; Russell and Botchan, 1995; Sun et al., 1996) and
ated wild-type probe was mixed with 200 ng of E1 and/or 40 ng of E2.Biotinyl
t sequences, single and double mutations in the E1BS and E2BS (Fig.
and unlabeled DNA prior to addition of protein.
w352 DIXON ET AL.FIG. 6. Oligonucleotide competition of E1 DNA binding. Lane 1, free wt, biotinylated probe; lanes 2–4, increasing amounts of wild-type HPV-11
unlabeled competitor DNA (5- to 100-fold molar excess); lanes 5–7, increasing amounts of a random binding site as an unlabeled competitor (RANBS).
For RANBS, both E1 and E2 binding sites were eliminated and the overall A/T richness was reduced. For quantitative comparison, the relative intensity
was set to 100% using the high-affinity E1/E2 complex. Pixel intensity was determined on a Fotodyne imager system.FIG. 7. Incorporation of [33P]dCTP into either (ori 2) PUC-18 or (HPV-11ori 1) PUC 18. Replication assays were as described under Materials and
Methods except that they contained 500 nM [33P]dCTP (120 mCi/nmol), and either 50 ng (ori 2) PUC-18 (triangles) or 50 ng ( HPV-11ori 1) PUC 18
(circles). Each 25 ml assay contained the indicated amount of E1 and either no E2 (open symbols) or 20 ng E2 (filled symbols). Replication products
ere captured on plates coated with linearized single-stranded PUC-18. Captured 33P was determined by liquid scintillation counting.
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353BINDING OF HPV TYPE 11 E1 HELICASE TO ORIGIN OF REPLICATIONlocalized to a 102-bp fragment adjacent to the E6 open
reading frame. This region contains three high-affinity E2
binding sites and an A/T-rich region that by alignment to
BPV, is commonly thought to contain the binding site for
E1. To more carefully study the interactions between
HPV11 E1, E2, and the origin of replication, we purified
and functionally characterized both E1 and E2 proteins
following expression in baculovirus and E. coli, respec-
tively. Expression and purification of E1 have traditionally
been very difficult, resulting in the vast majority of the
studies being conducted with E1 fusion proteins (e.g.,
GST) often without cleavage of the purification tag. To
more rigorously define the binding characteristics, we
elected to purify full-length, unfused, hopefully native
forms of both E1 and E2 (Rocque et al., 2000). To examine
he binding of the highly purified HPV-11 E1 and E2
roteins to the origin of replication, we used a modified
MSA in which low-stability complexes can be “cap-
ured” through the use of gluteraldehyde cross-linking.
Up until this time, there have been few demonstrations
f HPV E1 binding to origin DNA in the absence of E2. In
hese studies, we have clearly shown that HPV11 E1 can
ind origin DNA in a dose-dependent manner and that
1 association is stimulated by the presence of E2. Thus,
ike BPV1, E1 binding of DNA can occur and E2 stimu-
ates formation or stability of the complex. In contrast to
tudies with BPV E1 (Seo et al., 1993b) and HPV11 (Liu et
l., 1995), we observed no apparent stimulation of DNA
inding following addition of ATP-Mg21 or nonhydrolyz-
able analogs. Furthermore, we saw no effect on origin
DNA binding by E1 when the catalytic activities (includ-
ing both ATPase and helicase) were inactivated by con-
servative amino acid substitutions. More recent analysis
of BPV E1 would suggest that the effect of ATP-Mg21 is
primarily mediated through an increase in the half-life of
the complex from 18 to 60 min (Sanders and Stenlund,
1998) with no apparent effect on the formation of the
complex. Under the conditions utilized in this work, a
15-min binding reaction followed by gluteraldehyde
cross-linking, it is likely that results are primarily a mea-
sure of complex formation rather than complex stability.
Thus, we would conclude that neither ATP binding nor
hydrolysis plays an initial role in E1 DNA binding al-
though a role for ATP in complex stability has not yet
been investigated for HPV E1.
One of the distinct advantages of EMSA analysis of
DNA binding is that sequence specificity can be readily
examined. By analogy to BPV E1 and based upon limited
studies with HPV E1s (Frattini and Laimins, 1994a; Muller
et al., 1997; Sun et al., 1996), we anticipated that we could
ap sequence-specific binding of HPV11 E1 to a region
ithin the AT-rich segment of the HPV11 origin. In a
roader context, we looked to determine which binding
ites were critical for the cooperative formation of the
1/E2 DNA binding complex. A series of mutations withinhe E1, E2, or E1/E2 binding sites were analyzed by wMSA for their effects on cooperative binding. To elimi-
ate E2 binding, a traditional knockout was used in
hich the canonical CC and GG were changed to TAs.
s a guide to the elimination of E1 binding, since no
equence mapping studies have been done, we utilized
n origin mutant shown to be significantly impaired for in
itro replication (Russell and Botchan, 1995). Our results
emonstrate that the putative E1 binding site is not
ssential for DNA binding and does not enhance forma-
ion of the E1/E2/DNA complex. This finding correlates
ith observations that only the E2 binding sites are
bsolutely required for transient in vitro replication of an
PV-11 origin (Lu et al., 1993). To confirm that E1 has an
ntrinsic ability to bind DNA nonspecifically, we showed
y competition that E1 would bind as well to a nonspe-
ific oligonucleotide lacking either a putative E1BS or an
T-rich segment. Therefore, in the presence of a high-
ffinity E2 binding site with even small amounts E2 pro-
ein, E1 is recruited to the origin through direct interac-
ion with E2 and not necessarily via an E1 binding site.
hus, E2 can act in an auxiliary role as a regulator for E1
rigin binding.
An examination of the state of the purified E1 used in
his study revealed that E1 exists primarily as a hexamer
n the presence of a small but variable amount of mono-
er. Consequently, DNA binding of E1 alone and in
ooperation with E2 may be affected by the multimeric
tate of the protein. Data with BPV E1 suggest that E1
NA binding and multimerization proceed from a mono-
er through various states including a heteromeric com-
lex with E2 and a trimer of E1 to result in an active
exameric helicase with low sequence specificity. Thus,
he principal findings in this work are consistent in that
exameric HPV11 E1 appears to bind to the origin with-
ut intrinsic sequence specificity. Alternatively, if HPV11
1 indeed does not encode intrinsic sequence specificity
n the absence of E2, this would predict that an E1BS is
ot required for replication in cell culture and that in the
resence of E1 alone, an HPV origin should not be
equired for in vitro replication. Transient replication
tudies indicated that replication indeed required only
he presence of E2 binding sites (Lu et al., 1993), and
urther, data in this work (Fig. 6) show that in the pres-
nce of E1 alone, in vitro replication is equally efficient in
he presence or absence of origin sequences. It remains
o be determined, however, whether the sites of replica-
ion initiation differ in the presence of an origin and E1
lone.
In the course of this work, we sought to define condi-
ions other than simple dilution, which would drive the
onomer–hexamer equilibrium toward monomer in a
ashion similar to that described for SV40 T-Ag (Dean et
l., 1992). Unfortunately, we were unable to define such
onditions that permitted a high concentration of HPV11
1 monomer to be maintained in solution. Therefore, it
as not possible in these studies to distinguish DNA
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354 DIXON ET AL.binding specificity with respect to multimeric state. The
use of amino-terminal epitopes for E1 purification may be
serendipitously helpful through interference with multi-
merization resulting in a higher yield of monomer (Fouts
et al., 1999). Consequently, it is certainly possible that
xclusively monomeric E1 may have different sequence
pecificity than described herein.
As mentioned above, the technique used in this work
rimarily focused upon the formation of the E1/DNA
omplex. Ultimately, the stability or half-life of the com-
lex may be the best measure of relevant effects. The
tability of the complex may be affected by many features
ncluding DNA sequence and flexibility, phosphorylation
nd multimeric state of E1, and contributions from other
ofactors such as E2 or ATP binding. Indeed, our initial
bservations that E1 binding could select for T-rich oli-
onucleotides through immunoprecipitation suggest that
n E1/AT-rich DNA complex may be more stable than
hat formed with random DNA perhaps due to its inher-
ntly greater flexibility.
Among the nearly 100 different HPVs, there are sub-
tantial variations in tissue specificity and pathology.
herefore, it may not be surprising to find subtle regula-
ory differences that are mediated through variation in
rotein and nucleic acid interactions within the origin. It
s thought that both the expression and the coordination
f viral DNA replication are accomplished through the
nteractions of E1, E2, and various host transcription and
eplication factors. In the stratified, mucosal epithelium
f benign warts caused by HPV11, perhaps it is advan-
ageous for E1 DNA binding and replication initiation to
e mediated through the occupancy of the high-affinity
2BSs upstream of the E6 gene. At a superficial level,
here does appear to be additional evidence of variability
s HPV1 appears to replicate in the absence of E2 as a
ofactor (Gopalakrishnan and Khan, 1994) in contrast to
tudies with other HPVs including HPV11 (Del Vecchio et
al., 1992; Lu et al., 1993). DNA binding by E1 in the
absence of E2 has been noted for HPV31 (Frattini and
Laimins, 1994a), HPV33 (Muller et al., 1997), and HPV11
(Sun et al., 1996), but not for HPV16 E1 (Masterson et al.,
1998). Very recently, Liu et al. (1998) have shown that
HPV11 E1 DNA binding can be stimulated by the addition
of Hsp40 or Hsp70 chaperone proteins although the
sequence specificity of the enhanced binding was not
defined.
Comparison of sequences between SV-40 large-T an-
tigen and papillomaviruses suggests several conserved
regions that are involved in ATP binding (Clertant and
Seif, 1984). Similar to SV-40 large-T antigen, HPV-11 E1
contains sequences for a motif known as a phosphate
loop responsible for binding the a phosphate of a nucle-
tide. Subsequent work with SV-40 large-T antigen point
utations located within and adjacent to the P-loop ex-
ibited decreased ATP binding and in vitro replication
unction. Based on these mutant data for ATP bindingithin SV-40 large-T antigen and evidence that helicase
nd DNA replication activities of E1 are dependent on
TPase activity, a series of putative ATPase mutants was
enerated in HPV-11 E1 to ascertain whether DNA bind-
ng was critical for ATPase and replication activities. Four
utations were synthesized by site-directed oligo nucle-
tide mutagenesis; a proline to serine at position 479
as mutated in the P-loop, a lysine to glutamic acid was
ubstituted at position 484 in the GXXXXGK(T/S) consen-
us sequence of the P-loop, and conserved Walker B box
spartic acids were mutated to asparagine at positions
23 and 542.
We have previously demonstrated ATPase and DNA
elicase activities using wild-type HPV-11 E1 protein
Rocque et al., 2000). Table 1 is a compilation of our
mutant HPV-11 E1 functional data. We show that wild-
type E1 is able to hydrolyze ATP and that a proline to
serine site mutation in the P-loop retained ATPase activ-
ity in the absence of DNA. This E1 proline mutation
differs from an analogous mutation in HPV-6b (Hughes
and Romanos, 1993) by retaining ATPase and in vitro
replication activities. Mutations in lysine 484, aspartic
acid 523, and aspartic acid 542 all knocked out intrinsic
ATP binding activity. In contrast, only the lysine 484
mutant protein was unable to bind specifically to the
HPV-11 origin of replication. One possible explanation for
the lysine 484 mutation is that the amino acid substitu-
tion induces folding changes in E1 that lead to protein
instability and loss of DNA binding function. Since as-
partic acid mutations eliminated ATP binding, yet were
able to bind to the origin and interact with E2, we con-
cluded that DNA binding was not dependent upon
ATPase activity. Similar mutational results for HPV11
were recently published (Titolo et al., 1999).
In summary, we have provided evidence that (primarily
hexameric) E1 can bind to the HPV-11 origin of replica-
tion although with little or no sequence specificity and
that the critical site for high affinity E1/E2 complex for-
mation at the origin is the E2 binding site. Thus, despite
the conservation of replication functions among the an-
imal and human papillomaviruses, there may be subtle
but important differences between BPV-1 and some
HPVs in the assembly of an active replication complex.
MATERIALS AND METHODS
Expression and purification of human papillomavirus
type 11 E1
Wild-type HPV 11 E1 and E1 with amino acid substi-
tutions P479S, K484E, D523N, and D542N were purified
as described (Rocque et al., 2000). Briefly, baculovirus
infected T. ni cells (5 ml/g cells) expressing HPV11 E1
ere lysed in a ground glass homogenizer in 25 mM
EPES, pH 8.0, 10 mM NaCl, 1.5 mM MgCl , 1 mg/ml2
aprotinin, and leupeptin. Nuclei and cell debris were
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The supernatant was brought to 0.5% CHAPS and 1 mM
DTT and the solution was stirred for 20 min. The super-
natant was spun (25,000g) for 1 h. The resulting super-
natant was filtered through a 5-mm filter and loaded onto
a 200-ml heparin Sepharose column (XK 50/20, Pharma-
cia BioTech, Uppsala, Sweden) preequilibrated with 25
mM HEPES, pH 8.0, 0.1% CHAPS. Protein was eluted with
a 0–100% linear NaCl gradient of 25 mM HEPES, pH 8.0,
0.1% CHAPS, and 1 M NaCl. Fractions containing E1
were pooled and loaded directly onto a 20-ml E1 mAb
82.15 immunoaffinity column (5 mg antibody/ml resin)
constructed as described (McShan and Wilson, 1997)
using Fast Flow Immobilized rProtein A resin (Repligen,
Cambridge, MA). E1 was eluted with 50 mM HEPES, pH
8.0, 5 M LiCl and dialyzed against 25 mM HEPES, pH 8.0,
10% glycerol, 10 mM DTT. The starting cell mass for
purification of the mutant proteins was roughly 120 that of
the wild type. Each column was scaled down accordingly
and separate antibody columns were used for each mu-
tant to prevent cross-contamination.
Full-length HPV-11 E2 protein (42 kDa) or truncated
E2C (10 kDa) was cloned into a T7 expression vector and
expressed in BL21/DE3 E. coli. Cell pellets from 5-liter
cultures were suspended in 50 ml of buffer (20 mM
Tris/pH 8.5, 5 mM EDTA, 10 mM DTT, 1 mM PMSF) and
sonicated on ice. Disrupted cells were centrifuged for 20
min at 18,500 rpm. Supernatants were initially fraction-
ated on a heparin–agarose column with a 0 to 1 M NaCl
gradient. Positive, E2-containing fractions were applied
to a DNA affinity column containing two E2 binding sites.
E2 was eluted with a stepped gradient containing 0.36 M
NaCl, 20 mM Tris, pH 8.0, 1 mM EDTA, 0.1% Tween 20.
Pooled fractions were frozen and stored at 280°C.
Electrophoretic mobility shift assays
Double-stranded biotinylated oligonucleotides encom-
passing the HPV origin of replication were formed by incu-
bating complementary pairs of oligonucleotides in hybrid-
ization buffer as described (Kadonaga, 1986). Wild-type
HPV-11 origin DNA spanned nt 7904–50. This included a
putative E1 binding site and a proximal E2 binding site
flanked with an additional 12 nt (Fig. 1B). The comparable
DNA with base changes (nt 3–8, TTAATA to GGCCGC) was
used as the mutant E1 binding site probe. Base changes
within the wild-type origin (nt 36–37, CC to TA and nt 44–45,
GG to TA) were used as the mutant E2 binding site probe
and E1/E2 binding site mutant probes incorporated both
changes into the origin. Annealed and chemically labeled
DNA probes at a concentration of 10 pg/ml were used in
each band shift reaction. In studies with cold competitor,
double-stranded competitor sequences were added 10 min
prior to the labeled probe. Band shift assays were con-
ducted as described (Sedman and Stenlund, 1996) with the
exception that poly(dI–dC) was added as the nonspecificcompetitor. Unless indicated, the standard binding assay
contained 200 ng of E1 (136 nM) and 20 ng of E2 (24 nM) in
20 ml. Proteins and probe were mixed in a buffer containing
20 mM potassium phosphate, pH 7.5, 100 mM NaCl, 1 mM
EDTA, 0.7 mg/ml BSA, 2.5 mM DTT, 10% glycerol, and
poly(dI–dC) at 2 ng/ml. After 15 min at room temperature,
eactions were stopped with the addition of glutaraldehyde
o a final concentration of 0.02%, followed by 13 TBE
ample buffer. Separation of products was achieved by
lectrophoresis on 1% TBE agarose gels. After electro-
horesis, the DNA/protein complexes were electrotrans-
erred (0.53 TBE at 160 V for 1 h at 4°C) onto a positively
harged nylon membrane. The position of the labeled DNA
as detected by chemiluminescence using the protocol
nd reagents provided in the NEB Phototype Kit (New
ngland Biolabs, Beverly MA).
onstruction of human papillomavirus type 11 E1
oint mutants
Four amino acids in the HPV-11 E1 protein were changed
y site-directed mutagenesis of the plasmid pFB-BP-E1. The
utations were introduced using the QuickChange Site-
irected Mutagenesis kit from Stratagene (La Jolla, CA).
ach construct contained a single amino acid change:
P479S) proline 479 (CCA) to serine (TCA) using oligos
G36 (GCCATTGTAGGGTCACCTGACACTG) and RG37
CAGTGTCAGGTGACCCTACAATGGC); (K484E) lysine 484
AAG) to glutamic acid (GAG) using oligos RG38 (CACCT-
ACACTGGGGAGTCGTGCTTTTGC) and RG39 (GCAA-
AGCACGACTCCCCAGTGTCAGGTG); (D523N) aspartic
cid 523 (GAT) to asparagine (AAT) using oligos RG40
GCAAAAGTGGCATTATTGAATGATGCCACACAACC) and
G41 (GGTTGTGTGGCATCATTCAATAATGCCACTTTTGC);
nd (D542N) aspartic acid 542 (GAT) to asparagine (AAT)
sing oligos RG42 (CATATATGAGAAACCTATTAAATGGTA-
ATCCTATGAGC) and RG43 (GCTCATAGGATTACCATTTAAT-
AGGTTTCTCATATATG). Each substitution was confirmed by
DNA sequencing and the modified E1 gene was excised
from the parental plasmid with EcoRI and BamHI. The
constructs were then ligated into pFastBac (containing the
polyhedrin promoter). The entire E1 sequence of each mu-
tant was determined to confirm that no additional base
changes had occurred. These five sequences were com-
pared to the prototype sequence from GenBank (Accession
No. M14119). In the parental E1 sequence from pFB-BPE1,
five base changes with respect to the GenBank sequence
were found (base number based on GenBank sequence):
(1) 1107 A to C; no aa change; (2 and 3) 1083 C to G,1084 G
to C; aa 318: arginine to alanine; (4) 2538 C to T; no aa
change; (5) 2580 A to G, no aa change. The consensus
sequence for HPV group A10 E1 proteins also has an
alanine at position 318; therefore the sequence in pFast-
Bac-BP is closer to the consensus than the HPV-11 proto-
type in GenBank. These data have been previously re-
ported (Bream et al., 1993; Rocque et al., 2000).
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356 DIXON ET AL.In vitro DNA replication assay
The in vitro DNA replication assay was performed
asically as described (Kuo et al., 1994). Cellular extracts
were prepared from 293 cells grown in suspension in
serum-free IS 293 culture medium (Irvine Scientific) sup-
plemented with 0.1% Pluronic F-68 and 100 mg/ml sodium
heparin. In vitro DNA replication reactions (25 ml total)
ontained the following components: 30 mM HEPES
uffer, pH 7.5; 7 mM MgCl; 0.5 mM DTT; 0.1 mM each
ATP, dGTP, dTTP; 0.025 mM dCTP; 0.2 mM each GTP,
TP, CTP; 4 mM ATP; 40 mM phosphocreatine; 2.5 mg
creatine phosphokinase; 10 ml of 293 cell extract; 20 ng
urified E2; 200 ng purified E1; 50 ng plasmid DNA
B13854 containing a PCR fragment of the HPV11 origin
f replication bp 7870–99 cloned into the SmaI site of
UC18. Two hundred nanograms of SV40 large-T antigen
nd 50 ng p770.1 plasmid containing the SV40 origin of
eplication were included as positive controls. After re-
ctions were preincubated at 37°C for 1 h, 2.5 mCi
[a-32P]dCTP (at 3000 Ci/mmol) was added and reactions
ere incubated at 37°C for 2 h. Reactions were termi-
ated by adjusting concentration to 0.2% SDS, 10 mM
DTA, and 200 mg/ml Proteinase K and incubating at
7°C for 20 min. Twenty micrograms of glycogen was
dded as a carrier and reactions were ethanol precipi-
ated and then washed with 70% ethanol. Reaction prod-
cts were resuspended and electophoresed using a 1%
garose gel. Gels were dried and then quantified using
hosphorImager analysis (Storm 860, Molecular Dynam-
cs Inc.).
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